Deccan Health Care Ltd. · BSE:DECCAN
Deccan Health Care — Q2 FY2025-26 Earnings Presentation
13 slides from Deccan Health Care's earnings presentation, Nov 14, 2025
Slide 1: BSE Filing Cover Letter: Investors' Presentation on Q2 Results
Date: 14 November 2025 To, Corporate Relationship Department, BSE Limited PJ Towers, Dalal Street, Mumbai 400001, MH Stock Code: 542248 Subject: Investors’ Presentation on Financial Results for the Quarter ended 30 September 2025 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligation
Slide 2: Financial Highlights 2025–26 (Q2)
Financial Highlights 2025–26 (Q2)
Slide 3: Slide 3
Slide 4: Revenue
Revenue Standalone: Quarter Performance: ₹2,440.46 lakh (Growth: +29.7% YoY) Half-Yearly Performance: ₹4,587.41 lakh (Growth: +35.4% YoY) Q2 & H1 FY 2025–26 Consolidated: Quarter Performance: ₹2,139.56 lakh Half-Yearly Performance: ₹4,353.58 lakh Revenue Trend – Robust YoY growth driven by product d
Slide 5: Net Profit
Net Profit Standalone: Quarterly PAT: ₹89.97 lakh (Up: 67.5% YoY) Q2 & H1 FY 2025–26 Half-Yearly PAT: ₹111.22 lakh (Up: 22.8% YoY) Consolidated: Quarterly PAT: ₹91.40 lakh Half-Yearly PAT: ₹115.11 lakh Expected to sustain and increase in H2
Slide 6: EPS Trend
EPS Trend Increase to ₹0.36 vs ₹0.09 QoQ Q2 & H1 FY 2025–26 EPS steady and improving, signalling value accretion and expected to increase
Slide 7: EBITDA Margin
EBITDA Margin Q2 EBITDA: ₹171.08 lakh (+136% QoQ) Margin improved to 7.0% from 3.4% Q2 & H1 FY 2025–26 Strong scale efficiencies & cost discipline visible
Slide 8: Compliance & Governance
Compliance & Governance Zero investor complaints Timely MCA compliances Q2 & H1 FY 2025–26 Strong governance - this reinforces the company’s reputation for sound governance and responsible management.
Slide 9: Strategic Growth Drivers
Strategic Growth Drivers Weight Wellness Stronger presence in Continued focus Program driving functional foods on science-backed higher engagement (fruit bars, gummies) innovation Q2 & H1 FY 2025–26 An integrated, With innovative fruit The company remains science-backed bars and gummies, committed t
Slide 10: Export Expansion Outlook
Export Expansion Outlook Regulatory approvals UAE & GCC launch Large addressable filed in 6 international targeted for March market in preventive markets 2026 wellness Q2 & H1 FY 2025–26 Completed filings to With product Strong growth enable strategic launches in the UAE opportunity driven by intern
Slide 11: Take aways
Take aways Strong YoY revenue & profit growth momentum Rising EBITDA & margin expansion Q2 & H1 FY 2025–26 Strong equity base High-growth nutraceutical sector Export-driven multi-year growth visibility Strong governance and compliances
Slide 12: Disclaimer
Disclaimer: This communication, except for the historical information, may contain statements which reflect the Management’s current views and estimates and could be construed as forward-looking statements. The future involves many risks and uncertainties that could cause actual results to differ ma
Slide 13: Stay WoW
g Deccan q Healthcare Saw Limited =Stay WoW
Deccan Health Care — Q2 FY2025-26 Earnings Presentation on 6ix